This website is designed to provide information about the Add-Aspirin Trial, both for people taking part in the trial (participants) and collaborators. Please use the menus at the top of the screen to find out more about the trial.
Add-Aspirin is a large randomised clinical trial, which is taking place in the UK and India. It will recruit 11,000 participants to help find out whether regular aspirin use after treatment for an early stage cancer can prevent the cancer from coming back and preventing deaths.
Congratulations to our top 5 recruiting centres:
*FOR GENERAL AND CLINICAL QUERIES, PLEASE CHECK OUR FAQs*
We are thrilled to have more than 5000 patients registered on Add-Aspirin which reflects the hard work and dedication of staff across the UK and India. Over 2300 participants have now been registered in the breast cohort, and more than 3900 participants have been randomised overall.
We aim to recruit 3100 individuals who have had surgery to remove an early stage breast cancer.
Top recruiters: UHCW, Worcestershire Royal Hospital, Tata Memorial Hospital Mumbai, Royal Marsden Hospitals,
PARTICIPANTS REGISTERED: 2363
PARTICIPANTS RANDOMISED: 1906
We aim to to recruit 2600 individuals who have had surgery to remove an early stage bowel cancer.
Top recruiters: Bristol Haematology & Oncology Centre, St James 's University Hospital, Darlington Memorial Hospital
PARTICIPANTS REGISTERED: 1355
PARTICIPANTS RANDOMISED: 1072
We aim to recruit 2100 individuals who have had surgery or a combination of chemotherapy and radiotherapy to treat a cancer of the stomach or oesophagus (food pipe).
Tata Memorial Hospital Mumbai, The Christie, St James's University Hospital,
PARTICIPANTS REGISTERED: 248
PARTICIPANTS RANDOMISED: 183
We aim to recruit 2120 individuals who have had surgery or radiotherapy to treat an early stage prostate cancer.
Top recruiters: UCHW, University Hospital of Wales, Bristol Haematology & Oncology Centre
PARTICIPANTS REGISTERED: 1087
PARTICIPANTS RANDOMISED: 866